EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

HIV-1 prehairpin intermediate inhibitors show efficacy independent of neutralization tier

Benjamin N Bell iD, Theodora U J Bruun, Natalia Friedland, Peter S Kim iD

Proceedings of the National Academy of Sciences · 2023

DOI: 10.1073/pnas.2215792120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Benjamin N Bell und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305. Hauptthemen laut MEDLINE: Broadly Neutralizing Antibodies, HIV Infections, HIV-1. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HIV-1 strains are categorized into one of three neutralization tiers based on the relative ease by which they are neutralized by plasma from HIV-1–infected donors not on antiretroviral therapy; tier-1 strains are particularly sensitive to neutralization while tier-2 and tier-3 strains are increasingly difficult to neutralize. Most broadly neutralizing antibodies (bnAbs) previously described target the native prefusion conformation of HIV-1 Envelope (Env), but the relevance of the tiered categories for inhibitors targeting another Env conformation, the prehairpin intermediate, is not well understood. Here, we show that two inhibitors targeting distinct highly conserved regions of the prehairpin intermediate have strikingly consistent neutralization potencies (within ~100-fold for a given inhibitor) against strains in all three neutralization tiers of HIV-1; in contrast, best-in-class bnAbs targeting diverse Env epitopes vary by more than 10,000-fold in potency against these strains. Our results indicate that antisera-based HIV-1 neutralization tiers are not relevant for inhibitors targeting the prehairpin intermediate and highlight the potential for therapies and vaccine efforts targeting this conformation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Broadly Neutralizing AntibodiesHIV InfectionsHIV-1HumansAntibodies, Neutralizingenv Gene Products, Human Immunodeficiency VirusHIV AntibodiesNeutralization Tests

Stichwörter der Autor:innen

5-HelixHIV-1prehairpin intermediatetier-2 virustier-3 virus

Substanzen

Antibodies, NeutralizingBroadly Neutralizing Antibodiesenv Gene Products, Human Immunodeficiency VirusHIV Antibodies

Autor:innen und Institutionen

  • Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305.
  • Sarafan ChEM-H, Stanford University, Stanford, CA 94305.
  • Department of Biochemistry, Stanford University School of Medicine, Stanford, CA 94305.
  • Chan Zuckerberg Biohub, San Francisco, CA 94158.

ORCID-Profile: Benjamin N Bell, Peter S Kim

Förderung

  • NIAID NIH HHS
  • NIGMS NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases

Zitieren

APA

Bell, B. N., Bruun, T. U. J., Friedland, N., & Kim, P. S. (2023). HIV-1 prehairpin intermediate inhibitors show efficacy independent of neutralization tier. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2215792120

Vancouver

Bell BN, Bruun TUJ, Friedland N, Kim PS. HIV-1 prehairpin intermediate inhibitors show efficacy independent of neutralization tier. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2215792120

BibTeX
@article{Bell2023,
  author = {Bell, Benjamin N and Bruun, Theodora U J and Friedland, Natalia and Kim, Peter S},
  title = {HIV-1 prehairpin intermediate inhibitors show efficacy independent of neutralization tier},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2023},
  doi = {10.1073/pnas.2215792120}
}
Kostenlos starten →